T1D Exchange Co-Founder Dana Ball to Step Down as CEO
11 mai 2018 08h30 HE
|
T1D Exchange
BOSTON, May 11, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a patient-centered research organization dedicated to accelerating therapies and improving care for people with type 1 diabetes (T1D), today...
Innovators From 17 Countries Vie for $250,000 in Cash and In-Kind Support to Advance Diabetes Care in the 2018 Diabetes Innovation Challenge
20 mars 2018 08h15 HE
|
T1D Exchange
BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit research and collaboration organization dedicated to accelerating novel treatments to improve the care of people living with type...
Helmsley Charitable Trust Announces Funding Opportunity to Advance Disruptive Technologies for Type 1 Diabetes
16 janv. 2018 16h45 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Jan. 16, 2018 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program today announced a funding opportunity through the new Future...
JDRF welcomes CRA review of diabetes denials
08 déc. 2017 16h46 HE
|
Juvenile Diabetes Research Foundation Canada
TORONTO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The 300,000+ Canadians and their families living with type 1 diabetes (T1D) across the country welcome today’s announcement that the Government of Canada...
Media Advisory: Canada’s leading diabetes organizations to provide an update on efforts to reverse changes to the Disability Tax Credit
01 déc. 2017 17h57 HE
|
Juvenile Diabetes Research Foundation Canada
OTTAWA, Dec. 01, 2017 (GLOBE NEWSWIRE) -- WHAT: Canada’s leading diabetes organizations to host a NEWS CONFERENCE to provide new information about their efforts to reverse changes in...
Patient Entrepreneur Amin Zayani of Med Angel BV Selected as the Winner of the 2017 Lyfebulb-Novo Nordisk Innovation Award
08 nov. 2017 09h14 HE
|
Lyfebulb
COPENHAGEN, Denmark, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Patient Entrepreneur and Founder & CEO of Med Angel BV, Amin Zayani was named the recipient of the 2017 Lyfebulb-Novo Nordisk Innovation...
Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes
06 nov. 2017 09h00 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced five new grants that will support the European, multinational Global Platform for...
Patient Entrepreneur Finalists Announced for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award
10 oct. 2017 09h10 HE
|
Lyfebulb
NEW YORK, Oct. 10, 2017 (GLOBE NEWSWIRE) -- The finalists for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award have been announced today. The Summit and Award spotlights outstanding...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
16 mars 2017 09h33 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
16 mars 2017 09h33 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...